202 related articles for article (PubMed ID: 34192317)
1. Inhibition of miR-29 Activity in the Myeloid Lineage Increases Response to Calcitonin and Trabecular Bone Volume in Mice.
Shin B; Hrdlicka HC; Delany AM; Lee SK
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34192317
[TBL] [Abstract][Full Text] [Related]
2. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
3. LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL-Stimulated NF-κB and p38 Pathways During Osteoclastogenesis.
Lu D; Li J; Liu H; Foxa GE; Weaver K; Li J; Williams BO; Yang T
J Bone Miner Res; 2018 Oct; 33(10):1773-1784. PubMed ID: 29750835
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Lineage Ablation of
Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
[TBL] [Abstract][Full Text] [Related]
6. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
7. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
Zhao D; Shu B; Wang C; Zhao Y; Cheng W; Sha N; Li C; Wang Q; Lu S; Wang Y
J Cell Biochem; 2020 Jan; 121(1):152-164. PubMed ID: 31318102
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-29-3p isoforms via tough decoy suppresses osteoblast function in homeostasis but promotes intermittent parathyroid hormone-induced bone anabolism.
Hrdlicka HC; Pereira RC; Shin B; Yee SP; Deymier AC; Lee SK; Delany AM
Bone; 2021 Feb; 143():115779. PubMed ID: 33253931
[TBL] [Abstract][Full Text] [Related]
9. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration.
Franceschetti T; Kessler CB; Lee SK; Delany AM
J Biol Chem; 2013 Nov; 288(46):33347-60. PubMed ID: 24085298
[TBL] [Abstract][Full Text] [Related]
10. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
12. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y
Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)-
Ahn SH; Chen Z; Lee J; Lee SW; Min SH; Kim ND; Lee TH
Molecules; 2018 Nov; 23(12):. PubMed ID: 30501117
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
[TBL] [Abstract][Full Text] [Related]
15. The miR-29-3p family suppresses inflammatory osteolysis.
Shin B; Hrdlicka HC; Karki S; Fraser B; Lee SK; Delany AM
J Cell Physiol; 2024 May; ():. PubMed ID: 38764231
[TBL] [Abstract][Full Text] [Related]
16. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
[TBL] [Abstract][Full Text] [Related]
18. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
[TBL] [Abstract][Full Text] [Related]
20. Abnormal bone architecture in mice expressing MyD88 in cells of the osteoclast lineage.
Suren C; Lukashova L; Wischmann J; Wulsten D; Wildemann B; Von Eisenhart-Rothe R; Holzmann B; Mayer-Kuckuk P
J Biol Regul Homeost Agents; 2019; 33(4):1105-1111. PubMed ID: 31332987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
